Endocrine Abstracts

Currently national and international guidelines for imaging procedures for high risk and advanced prostate cancer (PCa) include abdomino-pelvic cross sectional imaging, multiparametric prostate MRI, bone scintigraphy and in the case of therapy monitoring of mCRPC whole body cross-sectional imaging mainly by means of computed tomography. Positron emission tomography (PET) has become increasingly important in the work-up of prostate cancer. Recently, a 68Gallium-label...